US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE BORDEAUX on Nov. 18 for "Tetramolecular parallel G-quadruplex-forming hydrophobically modified oligonucleotides" (French Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,325, issued on Nov. 18, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris) and UNIVERSITE DE BORDEAUX (Bordeaux, France).

"Tetramolecular parallel G-quadruplex-forming hydrophobically modified oligonucleotides" was invented by Philippe Barthelemy (Bordeaux, France), Arnaud Gissot (Bordeaux, France) and Brune Vialet (Bordeaux, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to tetramolecular parallel G-quadruplex-forming oligonucleotides. If G-quadruplexes are of prime importance in biology, their use is hampered by the pr...